T. Rowe Price Associates
IMMU

T. Rowe Price Associates’s Immunomedics Inc IMMU Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-1,337,049
Closed -$114M 2758
2020
Q3
$114M Sell
1,337,049
-5,542,557
-81% -$471M 0.01% 615
2020
Q2
$244M Buy
6,879,606
+1,950,783
+40% +$69.1M 0.03% 436
2020
Q1
$66.4M Sell
4,928,823
-899,168
-15% -$12.1M 0.01% 697
2019
Q4
$123M Sell
5,827,991
-77,288
-1% -$1.64M 0.02% 600
2019
Q3
$78.3M Sell
5,905,279
-245,585
-4% -$3.26M 0.01% 708
2019
Q2
$85.3M Sell
6,150,864
-2,959,466
-32% -$41M 0.01% 695
2019
Q1
$175M Sell
9,110,330
-3,704,693
-29% -$71.2M 0.03% 501
2018
Q4
$183M Buy
12,815,023
+226,388
+2% +$3.23M 0.03% 457
2018
Q3
$262M Buy
12,588,635
+3,818,816
+44% +$79.5M 0.04% 414
2018
Q2
$208M Buy
8,769,819
+1,790,358
+26% +$42.4M 0.03% 474
2018
Q1
$102M Buy
6,979,461
+351,799
+5% +$5.14M 0.02% 643
2017
Q4
$107M Buy
6,627,662
+251,530
+4% +$4.06M 0.02% 617
2017
Q3
$89.1M Buy
6,376,132
+408,370
+7% +$5.71M 0.02% 654
2017
Q2
$52.7M Buy
5,967,762
+1,271,920
+27% +$11.2M 0.01% 798
2017
Q1
$30.4M Buy
4,695,842
+4,570,042
+3,633% +$29.6M 0.01% 989
2016
Q4
$462K Buy
125,800
+12,700
+11% +$46.6K ﹤0.01% 2078
2016
Q3
$368K Buy
113,100
+80,000
+242% +$260K ﹤0.01% 2134
2016
Q2
$77K Hold
33,100
﹤0.01% 2454
2016
Q1
$83K Hold
33,100
﹤0.01% 2432
2015
Q4
$102K Buy
33,100
+300
+0.9% +$924 ﹤0.01% 2420
2015
Q3
$56K Hold
32,800
﹤0.01% 2463
2015
Q2
$133K Hold
32,800
﹤0.01% 2423
2015
Q1
$126K Hold
32,800
﹤0.01% 2436
2014
Q4
$157K Sell
32,800
-10,000
-23% -$47.9K ﹤0.01% 2405
2014
Q3
$159K Hold
42,800
﹤0.01% 2394
2014
Q2
$156K Buy
42,800
+13,000
+44% +$47.4K ﹤0.01% 2410
2014
Q1
$125K Hold
29,800
﹤0.01% 2408
2013
Q4
$137K Hold
29,800
﹤0.01% 2377
2013
Q3
$184K Hold
29,800
﹤0.01% 2287
2013
Q2
$162K Buy
+29,800
New +$162K ﹤0.01% 2250